% | $
Quotes you view appear here for quick access.

Inovio Pharmaceuticals, Inc. Message Board

  • martha.varias martha.varias Feb 9, 2013 9:06 AM Flag

    The Wall Street Journal Unleashing Innovation Conference, February 19-21

    Let's take a look at the executives of worldwide listed companies which participate with Dr. Kim in this meeting:

    Dmitry Grishin, Co-founder, CEO & Chairman, Mail Ru Group (Market cap 3 billion $)
    and Founder, Grishin Robotics

    Owen Mahoney
    CFO and CAO, Nexon (Market cap 5 billion $)

    Kiran Mazumdar-Shaw
    Chairman and Managing Director, Biocon (Market cap 57 billion $)

    Vineet Nayar
    Vice Chairman and CEO, HCL Technologies (Market cap 465 billion $)

    John G. Rice
    Vice Chairman, General Electric Company (Market cap 236 billion $)

    James E. Rogers
    Chairman, President and CEO, Duke Energy (Market cap 49 billion $)

    Eduardo Saverin
    Co-Founder, Facebook (Market cap 68 billion $)

    Tulsi Tanti
    Founder and Chairman, Suzlon Group (only Suzlon Energy has a market cap of 44 billion $)

    Jay S. Walker
    Founder, Priceline (Market cap 35 billion $)

    Gary Wang
    Founder, Tudou (Market cap 3.5 billion $)

    Ya-Qin Zhang
    Chairman, Microsoft Asia Pacific R&D Group and Corporate Vice President, Microsoft

    Now let's see the comment about Dr. Kim in this page:

    "J. Joseph Kim
    President & CEO, Inovio Pharmaceuticals

    Dr. J. Joseph Kim is President & CEO of Inovio Pharmaceuticals, a biotech company that is revolutionizing vaccines with DNA-sequenced vaccines for cancer, HIV, influenza and other infectious diseases.
    The Gates Foundation is funding his malaria vaccine, the Director of the National Institutes of Health called his flu vaccine "transformational medicine," and the U.S. NIH granted him $25 million to speed the development of his HIV vaccine.
    He earned a BS in Chemical Engineering and Economics from MIT, a PhD in Biochemical Engineering from the University of Pennsylvania, and an MBA in Finance from the Wharton School. Dr. Kim has published more than 100 peer-reviewed scientific papers, holds numerous patents and sits on several editorial boards and review panels."

    Question: After reading about the aforementioned participants and their companies, is there anyone who does not understand the significance of Inovio's President and CEO invitation in this meeting, among the executives of well established corporate giants?

    I believe it gives a good idea about what high profile experts think about the quality and the prospects of Dr. Kim's and his associates' work in Inovio.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
9.88+0.26(+2.70%)Jul 29 4:00 PMEDT